
Vyripharm Biopharmaceuticals is a disruptive biopharmaceutical and biotechnology innovator focused on personalized medicine. They integrate traditional and alternative medicines, aiming to transform medical paradigms by developing cutting-edge diagnostics and therapeutics for infectious diseases, neurological disorders, and cancer. Their unique positioning allows them to become a source for approved licensing in tracking, tracing, certifying, compliance, monitoring, and testing for agribiopharmaceutical products. The company leverages artificial intelligence through its BIOSYNC™ Platform, which integrates agribiopharmaceuticals with biopharmaceuticals and biotechnology for robust data management. Vyripharm Enterprises, Inc. is headquartered in the Texas Medical Center.

Vyripharm Biopharmaceuticals is a disruptive biopharmaceutical and biotechnology innovator focused on personalized medicine. They integrate traditional and alternative medicines, aiming to transform medical paradigms by developing cutting-edge diagnostics and therapeutics for infectious diseases, neurological disorders, and cancer. Their unique positioning allows them to become a source for approved licensing in tracking, tracing, certifying, compliance, monitoring, and testing for agribiopharmaceutical products. The company leverages artificial intelligence through its BIOSYNC™ Platform, which integrates agribiopharmaceuticals with biopharmaceuticals and biotechnology for robust data management. Vyripharm Enterprises, Inc. is headquartered in the Texas Medical Center.